Hanuveda
The Science of Ayurvedic Healing
The Science of Ayurvedic Healing
Never stop insulin in Type 1 diabetes.
Insulin is essential for survival, and stopping it can cause diabetic ketoacidosis (DKA).
Confirm the Type of Diabetes:
Some adults with LADA (latent autoimmune diabetes in adults) may initially be diagnosed as having Type 2 diabetes. Where autoimmune diabetes is suspected, appropriate medical assessment including GAD antibodies and C-peptide testing may help clarify the diagnosis and treatment requirements.
Ayurvedic Medicines & Hypoglycaemia
Some Ayurvedic medicines may lower blood glucose. Combined with insulin or sulfonylureas such as glimepiride or gliclazide, or with prolonged fasting, they may increase the risk of hypoglycaemia. Symptoms include sweating, shaking, palpitations, hunger, confusion and blurred vision. Regular glucose monitoring is important, and medication adjustments should be made with the treating physician.
SGLT2 Inhibitors & Fasting
If you take dapagliflozin, empagliflozin, canagliflozin or another SGLT2 inhibitor, inform your healthcare team before fasting or restrictive dietary programmes. These medicines can increase the risk of euglycaemic diabetic ketoacidosis, particularly during fasting, dehydration, illness, very-low-carbohydrate diets or reduced insulin use. Any temporary medication changes should be made only in consultation with your prescribing physician.
Outcome of Above Research – Standardized Ayurvedic polyherbal formulation (PHF) containing Cyperus rotundus, Berberis aristata, Cedrus deodara, Emblica officinalis, Terminalia chebula, and Terminalia bellirica produced beneficial effects on glycemic control and lipid profile in patients with type 2 diabetes. The formulation significantly improved blood glucose and HbA1c levels, while also reducing triglyceride and total cholesterol levels over six months. The study reported no adverse effects, supporting the potential of this formulation as a complementary approach to metabolic management, with further larger studies warranted to confirm its efficacy and mechanisms.
Outcome of Above Research – whole-system Ayurvedic intervention combining diet, exercise, meditation, and herbal supplementation may support metabolic health in newly diagnosed type 2 diabetes patients. Among participants with higher baseline HbA1c levels, the intervention demonstrated significant improvements in HbA1c, fasting glucose, total cholesterol, LDL cholesterol, and body weight. With 92% of participants completing the study and no significant study-related adverse events, the findings highlight the potential of an integrated Ayurvedic approach, while further research is needed to confirm its effectiveness.
Outcome of Above Research – several Ayurvedic medicines demonstrated potential benefits in improving glycemic control among patients with type 2 diabetes. Selected interventions achieved clinically meaningful reductions in HbA1c (≥0.3–0.4%), while fasting blood glucose decreased by approximately 4–56 mg/dL across different Ayurvedic medicines. The findings support the potential role of Ayurvedic therapies in diabetes management, although high-quality randomized controlled trials are needed to strengthen evidence regarding efficacy, safety, and standardization.
The classical premonitory features are specific: sweetness in the mouth, burning of palms and soles, excessive thirst, lassitude and heaviness, matting of the hair, a sense of coating on the teeth, sweet-smelling sweat with attraction of ants and flies, and turbidity of urine.
Excessive consumption of new grains, sweet preparations, curd and dairy products, jaggery, and heavy unctuous foods; Asya Sukha (sedentary comfort, literally the pleasure of sitting); Swapna Sukha (excessive sleep and day sleeping); and lack of exercise.
Stage 0 — Typing, screening and baseline
Establish the diabetes type first. GAD antibodies and C-peptide wherever there is any suggestion of autoimmune diabetes: lean build, absence of central obesity, personal or family autoimmune history, early failure of oral agents, or ketosis at diagnosis. Consider MODY in strong multi-generational young-onset family histories.
Complication screening — required, not optional:
Stage 1 — Agni correction and Ama pachana
The classical foundation, and the phase where Ayurveda’s metabolic reasoning is most coherent.
Stage 2 — Apatarpana and Rukshana (for Sthula Pramehi)
Stage 3 — Shodhana
Stage 4 — Shamana (internal medication)
Stage 5 — The lifestyle programme, which is where remission actually comes from
The honest frame
Outcomes we consider reasonable to expect
Outcomes we do not claim
Realistic timeline
How we measure it
No. But type 2 diabetes can go into remission — normal blood sugar without medication — and that is a real, documented outcome. In the DiRECT trial, 46% achieved remission at one year and 36% at two years. The critical detail is what produced it: weight loss. Over 80% of those who maintained more than 15 kg loss were in remission; none of those who gained weight achieved it. So remission is a legitimate goal, but it comes from sustained weight loss, not from a herb or a procedure.
Never insulin, and never on your own. For type 2 on oral agents, if your numbers improve substantially, dose reduction is a genuine possibility — but it is your physician's decision, made gradually with monitoring. We will write to them with your data. Be very cautious of any clinic that offers to take you off medication itself.
Ask for GAD antibodies and C-peptide if you are lean, developed diabetes without being overweight, have autoimmune conditions personally or in the family, or your tablets stopped working sooner than expected. LADA is regularly mislabelled as type 2, and the distinction decides whether reducing medication is ever safe for you. It is also why classical Ayurveda separated Sahaja (lean, congenital, incurable) from Apathyanimittaja (obese, lifestyle-related, manageable) Prameha.
It needs supervision, because several of the herbs genuinely lower glucose. Combined with sulfonylureas or insulin — or with fasting during Panchakarma — you can go too low. Watch for sweating, shaking, palpitations, hunger, confusion or blurred vision, and treat immediately with sugar. We require home monitoring and coordinate dose changes with your physician.
Yes, importantly. SGLT2 inhibitors carry a risk of euglycaemic ketoacidosis — ketoacidosis with normal-looking blood sugar, so your meter will not warn you. Fasting, low-carbohydrate eating and dehydration are documented precipitants, and Panchakarma involves all three. Tell us at your first consultation so the drug can be withheld around fasting procedures with your prescriber's agreement.
It depends mainly on three things: how long you have had diabetes, whether you are on insulin, and how much weight you can lose and keep
off. DiRECT enrolled people diagnosed within six years and not on insulin. If you fit that profile and can achieve substantial sustained weight loss, remission is a reasonable goal. If you have had diabetes for fifteen years and take insulin, better control is the realistic target — and it is still very much worth having. We will tell you honestly which group you are in.
Yes. Diabetic retinopathy causes no symptoms until sight is already at risk, and kidney damage is silent until late. Annual retinal examination and urine albumin testing prevent blindness and dialysis, and a better HbA1c does not remove the need for them. If you have never had these, arranging them matters more than anything else we do.
It requires modification, and sometimes it is not appropriate. Vamana raises intraocular and intracranial pressure and is contraindicated in proliferative retinopathy. Purgation risks dehydration, particularly on SGLT2 inhibitors. Autonomic neuropathy affects blood pressure regulation during heat therapies. Sensory loss in the feet means heat can burn you without your feeling it. This is why we require complication screening before enrolment rather than after.
Only with your medication reviewed first. Classical Prameha management does use depleting therapy, and it works — for the Sthula (obese) patient. But those texts were written before sulfonylureas, insulin and SGLT2 inhibitors existed. Fasting on those drugs is how people end up hypoglycaemic or in ketoacidosis. And if you are a lean diabetic, the classical instruction is the opposite: nourishing therapy, not depletion.
Patients seeking Ayurvedic treatment in India can avail of services tailored to their medical history, diagnosis, and prior treatments.
Traveling patients can be asked for past MRI/CT/X-ray reports, details about the diagnosis, history of the ongoing treatment, and current medications by the team beforehand.
During treatment, the team members can arrange the doctor’s consultation, planning of treatments, conduct the therapy sessions, organize the accommodation, and after-treatment follow-up to execute your treatment plan.
Patients seeking Ayurvedic treatment in India can avail of services tailored to their medical history, diagnosis, and prior treatments.
Our Doors Are Open for Your Healing Journey